InsiderTrades

Form 4 for AMPH Amphastar Pharmaceuticals, Inc.

Accepted 2024-11-13 00:00:00 ET · period of report 2024-11-12 · accession 0001415889-24-026756 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-11-13 2024-11-12 AMPH PRINS RICHARD K Dir S - Sale+OE $48.80 -5,000 31.5K -14% -$244.0K
D 2024-11-13 2024-11-12 AMPH PRINS RICHARD K Dir G - Gift $0.00 -1,000 30.5K -3% $0
D 2024-11-13 2024-11-12 AMPH PRINS RICHARD K Dir M - OptEx $16.69 +2,500 36.5K +7% +$41.7K
D 2024-11-13 2024-11-12 AMPH PRINS RICHARD K Dir M - OptEx $0.00 -2,500 4,179 -37% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-11-12 S D 5,000 $48.80 31,471 D — — (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.797 to $48.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
2 Common Common Stock 2024-11-12 G D 1,000 $0.00 30,471 D — —
3 Common Common Stock 2024-11-12 M A 2,500 $16.69 36,471 D — —
4 Derivative Stock Option (right to buy) 2024-11-12 M D 2,500 $0.00 4,179 D $16.69 · — to 2026-06-07 2,500 Common Stock (F2) Shares subject to the option are fully vested and immediately exercisable.